Press Releases Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-03 EDT			5-day change	1st Jan Change
22.93 ^USD	+4.04%		+9.87%	-36.90%

03-04	Prothena Names David Ford as Chief People Officer	MT
03-04	Prothena Appoints David Ford to Newly Created Chief People Officer	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prothena to Report First Quarter 2024 Financial Results on May 8	05-01	BU
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia and Lymphoma	04-16	AQ
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	04-15	BU
Prothena : Director's Report and Financial Statements for Fiscal Year 2023	03-29	PU
Prothena to Participate in Upcoming Healthcare Conferences	03-05	BU
Prothena Appoints David Ford to Newly Created Chief People Officer Position	03-04	BU
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate	02-21	BU
Prothena: Q4 Earnings Snapshot	02-15	AQ
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights	02-15	BU
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024	02-08	BU
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs	01-08	BU
Prothena: Q3 Earnings Snapshot	11-02	AQ
Prothena Reports Third Quarter 2023 Financial Results and Business Highlights	11-02	BU
Prothena to Report Third Quarter 2023 Financial Results on November 2	23-10-26	BU
AL Amyloidosis Pipeline, Clinical Trials Assessment, and NDA Approvals 2023 (Updated)	23-09-18	AQ
Prothena to Participate in Upcoming Healthcare Conferences	23-08-31	BU
Prothena : Corporate Overview	23-08-03	PU
Prothena Reports Second Quarter 2023 Financial Results and Business Highlights	23-08-03	BU
Prothena to Report Second Quarter 2023 Financial Results on August 3	23-07-27	BU
Prothena Presents New Research in the Treatment of Alzheimer's disease at Alzheimer's Association International Conference 2023	23-07-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Press Releases

Filters